Gene therapy Affinia Therapeutics picks up $110m Series B
Affinia Therapeutics, a gene therapy company, has secured $110 million in Series B financing.
Affinia Therapeutics, a gene therapy company, has secured $110 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination